Enalare Therapeutics is Therapeutic Devices in United States that focus on biopharmaceutical platform business. Founded in 2018. They cover business area such as developer, biopharmaceutical technology, therapy, patient, acute respiratory condition, pharmaceutical preparation, medical information, treatment, opioid addiction, dependence, agnostic therapeutic breathing stimulant, acute respiratory depression.
2018
( 6 years old in 2024 )
Biopharmaceutical Platform
-
161 Hodge Road
Princeton, NJ 08540
United States
Private
developerbiopharmaceutical technologytherapypatientacute respiratory conditionpharmaceutical preparationmedical informationtreatmentopioid addictiondependenceagnostic therapeutic breathing stimulantacute respiratory depression
* We use standard office opening hours in near Enalare Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Enalare Therapeutics is Therapeutic Devices business from United States that founded in 2018 (6 years old in 2024), Enalare Therapeutics business is focusing on Biopharmaceutical Platform.
Enalare Therapeutics headquarter office and corporate office address is located in 161 Hodge Road Princeton, NJ 08540 United States.
Enalare Therapeutics was founded in United States.
In 2024, Enalare Therapeutics is currently focus on biopharmaceutical platform sector.
Above is snippet of Google Trends for "biopharmaceutical platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Enalare Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
